(4S)-5-[[(2S,5S,8S,11R,12S,15S,18S,21R)-2-benzyl-15-[3-(diaminomethylideneazaniumyl)propyl]-21-hydroxy-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-3,6,9,13,16,22-hexaoxo-8-propan-2-yl-10-oxa-1,4,7,14,17-pentazabicyclo[16.3.1]docosan-12-yl]amino]-4-(hexanoylamino)-5-oxopentanoate

• 常用名: (4S)-5-[[(2S,5S,8S,11R,12S,15S,18S,21R)-2-benzyl-15-[3-(diaminomethylideneazaniumyl)propyl]-21-hydroxy-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-3,6,9,13,16,22-hexaoxo-8-propan-2-yl-10-oxa-1,4,7,14,17-pentazabicyclo[16.3.1]docosan-12-yl]amino]-4-(hexanoylamino)-5-oxopentanoate
• 英文名: (4S)-5-[[(2S,5S,8S,11R,12S,15S,18S,21R)-2-benzyl-15-[3-(diaminomethylideneazaniumyl)propyl]-21-hydroxy-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-3,6,9,13,16,22-hexaoxo-8-propan-2-yl-10-oxa-1,4,7,14,17-pentazabicyclo[16.3.1]docosan-12-yl]amino]-4-(hexanoylamino)-5-oxopentanoate
• CAS号: 914606-80-7
• 分子量: 1021.2
• 密度: N/A
• 沸点: N/A
• 分子式: C₅₀H₇₂N₁₀O₁₃
• 熔点: N/A
• 闪点: N/A

名称

• 英文名: (4S)-5-[[(2S,5S,8S,11R,12S,15S,18S,21R)-2-benzyl-15-[3-(diaminomethylideneazaniumyl)propyl]-21-hydroxy-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-3,6,9,13,16,22-hexaoxo-8-propan-2-yl-10-oxa-1,4,7,14,17-pentazabicyclo[16.3.1]docosan-12-yl]amino]-4-(hexanoylamino)-5-oxopentanoate

物理化学性质

• 分子式: C₅₀H₇₂N₁₀O₁₃
• 分子量: 1021.2
• InChIKey: NYXUAFLMUQAJPS-AYGLBTBXSA-N
• SMILES: CCCCCC(=O)NC(CCC(=O)[O-])C(=O)NC1C(=O)NC(CCC[NH+]=C(N)N)C(=O)NC2CCC(O)N(C2=O)C(Cc2ccccc2)C(=O)N(C)C(Cc2ccc(O)cc2)C(=O)NC(C(C)C)C(=O)OC1C

靶点实验

查看更多实验

实验名称：Inhibition of human LMW urokinase at < 2.5 uM 来源：ChEMBL 靶标：Urokinase-type plasminogen activator External Id：CHEMBL1173919

实验名称：Inhibition of thrombin at < 2.5 uM 来源：ChEMBL 靶标：Prothrombin External Id：CHEMBL1173918

实验名称：Inhibition of human tissue plasminogen activator at < 2.5 uM 来源：ChEMBL 靶标：Tissue-type plasminogen activator External Id：CHEMBL1173917

共3条，当前第1页，共1页

1